[1] Onuma AE, Zhang HJ, Gil L, et al.Surgical stress promotes tumor progression: a focus on the impact of the immune response[J]. J Clin Med. 2020; 9(12):4096. [2] Perera SK, Jacob S, Wilson BE, et al.Global demand for cancer surgery and an estimate of the optimal surgical and anaesthesia workforce between 2018 and 2040: a population-based modelling study[J]. Lancet Oncol. 2021; 22(2):182-189. [3] Ackerman RS, Luddy KA, Icard BE, et al.The Effects of Anesthetics and Perioperative Medications on Immune Function: A Narrative Review[J]. Anesth Analg. 2021; 133(3):676-689. [4] Pandya PH, Murray ME, Pollok KE, et al.The immune system in cancer pathogenesis: potential therapeutic approaches[J]. J Immunol Res. 2016; 4273943. [5] Wang L, Shen Y.Imbalance of circulating T-lymphocyte subpopulation in gastric cancer patiens correlated with performance status[J]. Clin Lab. 2013; 59(3-4):429-433. [6] 王俞, 崔书中. 恶性肿瘤患者的免疫功能状态及免疫治疗研究进展[J]. 中国肿瘤临床, 2014, 41(13):876-879. [7] Deng X, Terunuma H.Harnessing NK Cells to Control Metastasis[J].Vaccines (Basel). 2022; 10(12):2018. [8] Yap A, Lopez-Olivo MA, Dubowitz J, et al.Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia[J]. Can J Anaesth. 2019; 66(5):546-561. [9] Koutsogiannaki S, Bernier R, Tazawa K, et al.Volatile anesthetic attenuates phagocyte function and worsens bacterial loads in wounds[J]. J Surg Res. 2019; 233:323-330. [10] Jing Y, Zhang Y, Pan R, et al.Effect of Inhalation Anesthetics on Tumor Metastasis[J]. Technol Cancer Res Treat. 2022; 21:15330338221121092. [11] Loop T, Scheiermann P, Doviakue D, et al.Sevoflurane inhibits phorbol-myristate-acetate-induced activator protein-1 activation in human T lymphocytes in vitro: potential role of the p38-stress kinase pathway[J]. Anesthesiology. 2004; 101:710-721. [12] Xia SH, Zhou D, Ge F, et al.Influence of Perioperative Anesthesia on Cancer Recurrence: from Basic Science to Clinical Practice[J]. Curr Oncol Rep. 2023; 25(2):63-81. [13] Ma Z, Wang LZ, Cheng JT, et al. Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer Therapy[J]. Antioxid Redox Signal.2021, 20; 34(18):1484-1497. [14] Huang H, Benzonana LL, Zhao H, et al.Prostate cancer cell malignancy via modulation of HIF-1alpha pathway with isoflflurane and propofol alone and in combination[J]. Br J Cancer. 2014; 111:1338-1349. [15] Miklić Bublić M, Tonković D, Sakan S, et al.Effect of Inhalational Anesthetics on Acute Kidney Injury[J]. Acta Clin Croat. 2016; 55(3):464-468. [16] Sahinovic MM, Struys MMRF, Absalom AR.Clinical Pharmacokinetics and Pharmacodynamics of Propofol[J]. Clin pharmacokinet. 2018; 57(12):1539-1558 [17] Zhou M, Dai J, Zhou Y, et al.Propofol improves the function of natural killer cells from the peripheral blood of patients with esophageal squamous cell carcinoma[J]. Exp Ther Med. 2018; 16(1):83-92. [18] Xia SH, Zhou D, Ge F, et al.Influence of Perioperative Anesthesia on Cancer Recurrence: from Basic Science to Clinical Practice[J]. Curr Oncol Rep. 2023; 25(2): 63-81. [19] Zhang T, Fan Y, Liu K, et al.Effects of different general anesthetic techniques on immune responses in patients undergoing surgery for tongue cancer[J]. Anaesth Intensive Care. 2014; 42:220-227. [20] Oh CS, Park HJ, Piao L, et al.Expression Profiles of Immune Cells after Propofol or Sevoflurane Anesthesia for Colorectal Cancer Surgery: A Prospective Double-blind Randomized Trial[J]. Anesthesiology. 2022; 136(3):448-458. [21] Gu L, Pan X, Wang C, et al.The benefits of propofol on cancer treatment: Decipher its modulation code to immunocytes[J]. Front Pharmacol. 2022; 13:919636. [22] Wu ZF, Lee MS, Wong CS, et al.Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in colon cancer surgery[J]. Anesthesiology. 2018; 129(5):932-941. [23] Enlund M, Berglund A, Andreasson K, et al.The choice of anesthetic-sevoflurane or propofol-and outcome from cancer surgery: a retrospective analysis[J]. Ups J Med Sci. 2014; 119:251-261. [24] Lim A, Braat S, Hiller J, et al.Inhalational versus propofol based total intravenous anaesthesia: practice patterns and perspectives among Australasian anesthetists[J]. Anesth Intensive Care. 2018; 46:480-487. [25] Wang K, Li C.Effects of dexmedetomidine on inflammatory factors, T lymphocyte subsets and expression of NF-κB in peripheral blood mononuclear cells in patients receiving radical surgery of colon carcinoma[J]. Oncol Lett. 2018; 15(5):7153-7157. [26] Yang XH, Bai Q, Lv MM, et al.Effect of dexmedetomi-dine on immune function of patients undergoing radical mastectomy: a double blind and placebo control study[J]. Eur Rev Med Pharmacol Sci. 2017; 21(5):1112-1116. [27] Lee S.Dexmedetomidine: present and future directions[J]. Korean J Anesthesiol. 2019; 72(4):323-330. [28] Cole SW, Nagaraja AS, Lutgendorf SK, et al.Sympathetic nervous system regulation of the tumour microenvironment[J]. Nat Rev Cancer. 2015; 15:563-572. [29] Liu Z, Wang Y, Wang Y, et al.Dexmedetomidine attenuates inflammatory reaction in the lung tissues of septic mice by activating cholinergic anti-inflammatory pathway[J]. Int Immunopharmacol. 2016; 35:210-216. [30] Wang K, Wu M, Xu J, et al.Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis[J]. Br J Anaesthesia. 2019; 123(6):777-794. [31] Huang L, Qin C, Wang L, et al.Effects of dexmedeto-midine on immune response in patients undergoing radical and reconstructive surgery for oral cancer[J]. Oncol Lett. 2021; 21(2):106. [32] Eisenstein TK.The role of opioid receptors in immune system function[J]. Front Immunol. 2019; 10:2904. [33] Plein LM, Rittner HL.Opioids and the immune system-friend or foe[J]. Br J Pharmacol. 2018; 175:2717-2725. [34] Zhao L, Teng L, Zhang W, et al.Dose of intra-operative opioids has no impact on recurrence or survival in primary liver cancer[J]. Cancer Med. 2022; 11(24):4927-4934. [35] Cronin AJ, Aucutt-Walter NM, Budinetz T, et al.Low-dose remifentanil infusion does not impair natural killer cell function in healthy volunteers[J]. Br J Anaesth. 2003; 91:805-809. [36] Moyano J, Aguirre L.Opioids in the immune system: from experimental studies to clinical practice[J]. Rev Assoc Med Bras. 2019; 65:262-269. [37] Longhini F, Bruni A, Garofalo E, et al.Anesthetic strategies in oncological surgery: not only a simple sleep, but also impact on immunosuppression and cancer recurrence[J]. Cancer Manag Res. 2020; 12:931-940. [38] Zhang D, Jiang J, Liu J, et al.Effects of Perioperative Epidural Analgesia on Cancer Recurrence and Survival[J]. Front Oncol. 2022; 11:798435. [39] Gu C, Wang L, He Y, et al.Effect of Local Versus General Anesthesia in Breast-Conserving Surgery on Cancer Recurrence and Cost[J]. Cancer Control. 2022; 29:10732748221083078. |